Silverstein, J., Tseng, C., Grande, I., Rio, L. D., Kivork, C., Garcia, E. I., Chauv, J., Kubalanza, K., Konecny, G. E. (2026). Updated efficacy, safety, and exploratory biomarker analyses of a phase II trial of abemaciclib plus hormonal therapy in recurrent ovarian (OC) and endometrial cancer (EC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.5516